BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

In light of the adverse prognosis related to severe mitral regurgitation, heart failure, or
sudden cardiac death in a subset of patients with mitral valve prolapse (MVP), identifying …

Mitral valve prolapse (MVP) is a common condition affecting 2–3% of the general
population, and the most complex form of valve pathology, with a complication rate up to 10 …

Aims Degenerative mitral valve dystrophy (MVD) leading to mitral valve prolapse is the most
frequent form of MV disease, and there is currently no pharmacological treatment available …

Valvular heart disease (VHD) is becoming more prevalent in an ageing population, leading
to challenges in diagnosis and management. This two-part Series offers a comprehensive …

Mitral valve prolapse (MVP) has a prevalence of 2–3% among the population. It involves a
heterogeneous group of patients with different expressions and according to the phenotype …

Mitral valve prolapse (MVP) represents the most frequent cause of primary mitral
regurgitation. For several years, biological mechanisms underlying this condition attracted …

BACKGROUND: Mitral valve (MV) disease including myxomatous degeneration is the most
common form of valvular heart disease with an age-dependent frequency. Genetic evidence …

Background: Mitral valve (MV) disease including myxomatous degeneration is the most
common form of valvular heart disease with an age-dependent frequency. Genetic evidence …

Valvulopathies are among the most common cardiovascular diseases, significantly
increasing morbidity and mortality. While many valvular heart diseases are acquired later in …